4月 2026
- 首頁
- Lunatus - Healthcare
4月 2026Lunatus - Healthcare的市場佔有率分析
lunatus is the regions leading full-service healthcare marketing & distribution company in the middle east.
Lunatus - Healthcare(包含公司地區)
查看更多網站流量與參與度資訊- lunatus.com
Lunatus - Healthcare的熱門網域總造訪量
了解Lunatus - Healthcare市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Lunatus - Healthcare的熱門網域平均造訪時長
分析Lunatus - Healthcare參與度指標。
過去 3 個月平均造訪時長
子公司細目
Lunatus - Healthcare的熱門網域平均頁面瀏覽量
了解Lunatus - Healthcare如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Lunatus - Healthcare
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Lunatus & Marubeni Partnership partnered with Hartington Group on Jan 6th '26.Lunatus Marketing and Consulting FZCO, a leading turnkey partner for pharmaceutical and healthcare companies in the Middle East, today announced the signing of an exclusive agency agreement with Hartington Pharmaceutical SLU to commercialize NASODREN(R) Nasal Spray across nine territories in the region: Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain, Oman, Iraq, Jordan, and Lebanon.
1月 6, 2026閱讀更多
新聞Lunatus & Marubeni Partnership partnered with KYORIN Pharmaceutical Co., Ltd on Jan 5th '26.Lunatus Marketing & Consulting FZCO, a leading turnkey partner for pharmaceutical and healthcare companies in the Middle East, today announced the signing of an exclusive agency agreement with KYORIN Pharmaceutical Co., Ltd., a Japan-based research-driven pharmaceutical company, for Lasvic(R) tablets (lascufloxacin hydrochloride) across nine Middle Eastern countries.
1月 5, 2026閱讀更多
查看所有Lunatus - Healthcare信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
